Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases
- PMID: 8754845
- PMCID: PMC231443
- DOI: 10.1128/MCB.16.8.4445
Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases
Abstract
Rat fibroblasts transformed by a temperature-sensitive mutant of murine p53 undergo a reversible growth arrest in G1 at 32.5 degrees C, the temperature at which p53 adopts a wild-type conformation. The arrested cells contain inactive cyclin-dependent kinase 2 (cdk2) despite the presence of high levels of cyclin E and cdk-activating kinase activity. This is due in part to p53-dependent expression of the p2l cdk inhibitor. Upon shift to 39 degrees C, wild-type p53 is lost and cdk2 activation and pRb phosphorylation occur concomitantly with loss of p2l. This p53-mediated growth arrest can be abrogated by overexpression of cdk4 and cdk6 but not cdk2 or cyclins, leading to continuous proliferation of transfected cells in the presence of wild-type p53 and p2l. Kinase-inactive counterparts of cdk4 and cdk6 also rescue these cells from growth arrest, implicating a noncatalytic role for cdk4 and cdk6 in this resistance to p53-mediated growth arrest. Aberrant expression of these cell cycle kinases may thus result in an oncogenic interference with inhibitors of cell cycle progression.
Similar articles
-
Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.Blood. 2000 Oct 15;96(8):2746-54. Blood. 2000. PMID: 11023508
-
[Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].Cancer Radiother. 2001 Apr;5(2):109-29. doi: 10.1016/s1278-3218(01)00087-7. Cancer Radiother. 2001. PMID: 11355576 Review. French.
-
Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.Oncogene. 1998 Nov 5;17(18):2393-402. doi: 10.1038/sj.onc.1202322. Oncogene. 1998. PMID: 9811471
-
TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.J Immunol. 1998 Jan 15;160(2):770-7. J Immunol. 1998. PMID: 9551912
-
P53, cyclin-dependent kinase and abnormal amplification of centrosomes.Biochim Biophys Acta. 2008 Sep;1786(1):15-23. doi: 10.1016/j.bbcan.2008.04.002. Epub 2008 Apr 22. Biochim Biophys Acta. 2008. PMID: 18472015 Free PMC article. Review.
Cited by
-
Control of cyclin D1, p27(Kip1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension.Mol Biol Cell. 1998 Nov;9(11):3179-93. doi: 10.1091/mbc.9.11.3179. Mol Biol Cell. 1998. PMID: 9802905 Free PMC article.
-
Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution.Mol Cell Biol. 1997 Jul;17(7):4059-69. doi: 10.1128/MCB.17.7.4059. Mol Cell Biol. 1997. PMID: 9199341 Free PMC article.
-
Forestalling age-impaired angiogenesis and blood flow by targeting NOX: Interplay of NOX1, IL-6, and SASP in propagating cell senescence.Proc Natl Acad Sci U S A. 2021 Oct 19;118(42):e2015666118. doi: 10.1073/pnas.2015666118. Proc Natl Acad Sci U S A. 2021. PMID: 34654740 Free PMC article.
-
Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression.Mol Cell Biol. 1998 Sep;18(9):5284-90. doi: 10.1128/MCB.18.9.5284. Mol Cell Biol. 1998. PMID: 9710613 Free PMC article.
-
Inosine-5'-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation.Mol Biol Cell. 1998 Jan;9(1):15-28. doi: 10.1091/mbc.9.1.15. Mol Biol Cell. 1998. PMID: 9436988 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous